ToS;DR

4-AcO DMT


Service: Fatafeat
Status: DECLINED
Case: Extra data may be collected about you through promotions
Changes: 2
Source: link
Author: landrin (35258)


The number of novel psychedelic phenethylamines and tryptamines has continued to increase, but little academic research has focused on the effects of these substances. We sought to determine and compare the subjective effects of various substances. <p><a href="https://psychedeliccubensis.com/product/4-aco-dmt/">4-AcO DMT</a></p> We conducted in-depth interviews with 39 adults (75.4% male and 87.2% White) who reported experience using psychedelic phenethylamines and/or tryptamines. Participants described the effects of compounds they have used. We examined the subjective drug effects in a qualitative descriptive manner.<p><a href="https://psychedeliccubensis.com/product/4-aco-dmt/">4-AcO DMT</a></p> Participants reported on the use of 36 compounds. The majority (64.1%) reported the use of 2C series drugs, with 2C-B use being most prevalent; 38.5% reported the use of NBOMe, and 25.6% reported the use of DOx. With regard to tryptamines, 46.2% reported use, and 4-AcO-DMT was the most prevalent drug used in this class. 2C-B was often described as being more favorable than other 2C series compounds with the effects described as being comparable with MDMA and LSD. NBOMe effects were generally described in an unfavorable manner, and the effects of DOx were often described as lasting too long (12–36 hr). The effects of 4-AcO-DMT were often described as mimicking psilocybin.<p><a href="https://psychedeliccubensis.com/product/4-aco-dmt/">4-AcO DMT</a></p>


Comments:
No comments found


We track editorial changes to analyses and updates to a point's status and display the previous versions here as part of an effort to promote transparency regarding our curation process.

Version 1: 2024-01-07 21:28:10 UTC by ThisIsLiz (26655)

Previous Title: No changes recorded

Updated Title: No changes recorded

Previous Analysis: No changes recorded

Updated Analysis: No changes recorded

Previous Status: PENDING

Updated Status: DECLINED

Version 2: 2024-01-07 01:54:26 UTC by landrin (35258)

Previous Title:

Updated Title: 4-AcO DMT

Previous Analysis:

Updated Analysis: The number of novel psychedelic phenethylamines and tryptamines has continued to increase, but little academic research has focused on the effects of these substances. We sought to determine and compare the subjective effects of various substances. <p><a href="https://psychedeliccubensis.com/product/4-aco-dmt/">4-AcO DMT</a></p> We conducted in-depth interviews with 39 adults (75.4% male and 87.2% White) who reported experience using psychedelic phenethylamines and/or tryptamines. Participants described the effects of compounds they have used. We examined the subjective drug effects in a qualitative descriptive manner.<p><a href="https://psychedeliccubensis.com/product/4-aco-dmt/">4-AcO DMT</a></p> Participants reported on the use of 36 compounds. The majority (64.1%) reported the use of 2C series drugs, with 2C-B use being most prevalent; 38.5% reported the use of NBOMe, and 25.6% reported the use of DOx. With regard to tryptamines, 46.2% reported use, and 4-AcO-DMT was the most prevalent drug used in this class. 2C-B was often described as being more favorable than other 2C series compounds with the effects described as being comparable with MDMA and LSD. NBOMe effects were generally described in an unfavorable manner, and the effects of DOx were often described as lasting too long (12–36 hr). The effects of 4-AcO-DMT were often described as mimicking psilocybin.<p><a href="https://psychedeliccubensis.com/product/4-aco-dmt/">4-AcO DMT</a></p>

Previous Status:

Updated Status: PENDING